216 related articles for article (PubMed ID: 23565194)
1. A prognosis classifier for breast cancer based on conserved gene regulation between mammary gland development and tumorigenesis: a multiscale statistical model.
Tian Y; Chen B; Guan P; Kang Y; Lu Z
PLoS One; 2013; 8(4):e60131. PubMed ID: 23565194
[TBL] [Abstract][Full Text] [Related]
2. RUNX2 in mammary gland development and breast cancer.
Ferrari N; McDonald L; Morris JS; Cameron ER; Blyth K
J Cell Physiol; 2013 Jun; 228(6):1137-42. PubMed ID: 23169547
[TBL] [Abstract][Full Text] [Related]
3. TOX3 is expressed in mammary ER(+) epithelial cells and regulates ER target genes in luminal breast cancer.
Seksenyan A; Kadavallore A; Walts AE; de la Torre B; Berel D; Strom SP; Aliahmad P; Funari VA; Kaye J
BMC Cancer; 2015 Jan; 15():22. PubMed ID: 25632947
[TBL] [Abstract][Full Text] [Related]
4. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling during mammary epithelial cell three-dimensional morphogenesis identifies PTPRO as a novel regulator of morphogenesis and ErbB2-mediated transformation.
Yu M; Lin G; Arshadi N; Kalatskaya I; Xue B; Haider S; Nguyen F; Boutros PC; Elson A; Muthuswamy LB; Tonks NK; Muthuswamy SK
Mol Cell Biol; 2012 Oct; 32(19):3913-24. PubMed ID: 22851698
[TBL] [Abstract][Full Text] [Related]
6. A three-gene model to robustly identify breast cancer molecular subtypes.
Haibe-Kains B; Desmedt C; Loi S; Culhane AC; Bontempi G; Quackenbush J; Sotiriou C
J Natl Cancer Inst; 2012 Feb; 104(4):311-25. PubMed ID: 22262870
[TBL] [Abstract][Full Text] [Related]
7. Contributions of the RhoA guanine nucleotide exchange factor Net1 to polyoma middle T antigen-mediated mammary gland tumorigenesis and metastasis.
Zuo Y; Ulu A; Chang JT; Frost JA
Breast Cancer Res; 2018 May; 20(1):41. PubMed ID: 29769144
[TBL] [Abstract][Full Text] [Related]
8. An RNA-seq-based gene expression profiling of radiation-induced tumorigenic mammary epithelial cells.
Ma L; Nie L; Liu J; Zhang B; Song S; Sun M; Yang J; Yang Y; Fang X; Hu S; Zhao Y; Yu J
Genomics Proteomics Bioinformatics; 2012 Dec; 10(6):326-35. PubMed ID: 23317700
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional control of the cell cycle in mammary gland development and tumorigenesis.
Coletta RD; Jedlicka P; Gutierrez-Hartmann A; Ford HL
J Mammary Gland Biol Neoplasia; 2004 Jan; 9(1):39-53. PubMed ID: 15082917
[TBL] [Abstract][Full Text] [Related]
10. Mammary development and breast cancer: the role of stem cells.
Ercan C; van Diest PJ; Vooijs M
Curr Mol Med; 2011 Jun; 11(4):270-85. PubMed ID: 21506923
[TBL] [Abstract][Full Text] [Related]
11. The impact of transgenic IGF-IR overexpression on mammary development and tumorigenesis.
Jones RA; Moorehead RA
J Mammary Gland Biol Neoplasia; 2008 Dec; 13(4):407-13. PubMed ID: 19002570
[TBL] [Abstract][Full Text] [Related]
12. A mouse mammary gland involution mRNA signature identifies biological pathways potentially associated with breast cancer metastasis.
Stein T; Salomonis N; Nuyten DS; van de Vijver MJ; Gusterson BA
J Mammary Gland Biol Neoplasia; 2009 Jun; 14(2):99-116. PubMed ID: 19408105
[TBL] [Abstract][Full Text] [Related]
13. The Discovery of Novel Biomarkers Improves Breast Cancer Intrinsic Subtype Prediction and Reconciles the Labels in the METABRIC Data Set.
Milioli HH; Vimieiro R; Riveros C; Tishchenko I; Berretta R; Moscato P
PLoS One; 2015; 10(7):e0129711. PubMed ID: 26132585
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic and Transcriptomic Profiling of Mammary Gland Development and Tumor Models Disclose Regulators of Cell State Plasticity.
Dravis C; Chung CY; Lytle NK; Herrera-Valdez J; Luna G; Trejo CL; Reya T; Wahl GM
Cancer Cell; 2018 Sep; 34(3):466-482.e6. PubMed ID: 30174241
[TBL] [Abstract][Full Text] [Related]
15. Crosstalk between STAT5 activation and PI3K/AKT functions in normal and transformed mammary epithelial cells.
Rädler PD; Wehde BL; Wagner KU
Mol Cell Endocrinol; 2017 Aug; 451():31-39. PubMed ID: 28495456
[TBL] [Abstract][Full Text] [Related]
16. The chemokine receptor CCR7 promotes mammary tumorigenesis through amplification of stem-like cells.
Boyle ST; Ingman WV; Poltavets V; Faulkner JW; Whitfield RJ; McColl SR; Kochetkova M
Oncogene; 2016 Jan; 35(1):105-15. PubMed ID: 25772241
[TBL] [Abstract][Full Text] [Related]
17. Reprogramming of the estrogen responsive transcriptome contributes to tamoxifen-dependent protection against tumorigenesis in the p53 null mammary epithelial cells.
Palaniappan M; Edwards D; Creighton CJ; Medina D; Conneely OM
PLoS One; 2018; 13(3):e0194913. PubMed ID: 29590203
[TBL] [Abstract][Full Text] [Related]
18. Epigenetic reprogramming governs EcSOD expression during human mammary epithelial cell differentiation, tumorigenesis and metastasis.
Teoh-Fitzgerald ML; Fitzgerald MP; Zhong W; Askeland RW; Domann FE
Oncogene; 2014 Jan; 33(3):358-68. PubMed ID: 23318435
[TBL] [Abstract][Full Text] [Related]
19. Transcriptome analyses of mouse and human mammary cell subpopulations reveal multiple conserved genes and pathways.
Lim E; Wu D; Pal B; Bouras T; Asselin-Labat ML; Vaillant F; Yagita H; Lindeman GJ; Smyth GK; Visvader JE
Breast Cancer Res; 2010; 12(2):R21. PubMed ID: 20346151
[TBL] [Abstract][Full Text] [Related]
20. Reversal by RARα agonist Am580 of c-Myc-induced imbalance in RARα/RARγ expression during MMTV-Myc tumorigenesis.
Bosch A; Bertran SP; Lu Y; Garcia A; Jones AM; Dawson MI; Farias EF
Breast Cancer Res; 2012 Aug; 14(4):R121. PubMed ID: 22920668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
